IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 184 filers reported holding IMPAX LABORATORIES INC in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,628,000 | -4.1% | 50,844 | +30.6% | 0.00% | 0.0% |
| Q4 2015 | $1,698,000 | +0.6% | 38,922 | -18.8% | 0.00% | 0.0% |
| Q3 2015 | $1,688,000 | -39.4% | 47,958 | -20.9% | 0.00% | -25.0% |
| Q2 2015 | $2,785,000 | -7.9% | 60,643 | -6.0% | 0.00% | -33.3% |
| Q1 2015 | $3,023,000 | +10.2% | 64,501 | -24.7% | 0.01% | +20.0% |
| Q4 2014 | $2,743,000 | -51.5% | 85,686 | -64.1% | 0.01% | -50.0% |
| Q3 2014 | $5,652,000 | +56.2% | 238,394 | +54.2% | 0.01% | +66.7% |
| Q2 2014 | $3,619,000 | +484.7% | 154,606 | +560.0% | 0.01% | +500.0% |
| Q1 2014 | $619,000 | -40.1% | 23,424 | -46.5% | 0.00% | -50.0% |
| Q4 2013 | $1,033,000 | +118.9% | 43,824 | +90.4% | 0.00% | +100.0% |
| Q3 2013 | $472,000 | +604.5% | 23,015 | +589.1% | 0.00% | – |
| Q2 2013 | $67,000 | – | 3,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |